[1]
Atif Ibrahim, Sumair Ozair, Gene Gerlach, and Barry Bertolet*, “A Brief Review of Clinical Considerations for Healthcare Provider-Administered Cardiovascular Risk Modifying Medications”, J Cardiovasc Med Cardiol, pp. 011–014, Jan. 2025.